Loading people...
Denise Terry is a finance, operations, and digital health executive currently based in the San Francisco Bay Area. She previously served as the Director of Finance and Operations at Precursor Ventures, where she supported a venture capital portfolio of over 100 early-stage investments. Prior to this role, Terry held strategic finance positions at prominent technology startups, including the automated investment service Wealthfront and the grocery delivery platform Good Eggs. In the healthcare sector, she was the Co-Founder and Chief Executive Officer of EmbraceHer Health, an early-stage digital health company focused on maternity and women's wellness. Before entering the technology industry, she earned a Bachelor of Arts in Economics from Smith College. Her career focuses on scaling early-stage technology companies through financial leadership, operational strategy, and specialized product development across the healthcare and fintech sectors.
Denise Terry stands as a pivotal leader in the biotechnology sector, currently serving as the Head of Marketing at Karius, Inc. In this crucial role, she is instrumental in shaping the brand narrative and market strategy for a company at the forefront of infectious disease diagnostics. Karius, Inc. is renowned for its innovative Karius Test, a next-generation sequencing liquid biopsy that helps clinicians rapidly and accurately detect over 1,000 pathogens from a single blood sample, transforming patient care for those with suspected infections.
As Head of Marketing, Denise Terry's 'investment focus' is squarely on driving Karius' commercial success and expanding its global footprint. This involves strategic planning for product launches, developing compelling brand messaging, and implementing robust digital marketing campaigns to educate healthcare providers and patients about the life-saving potential of Karius' technology. Her leadership ensures that Karius' groundbreaking science is translated into clear, impactful communications that resonate across diverse audiences, from clinicians to hospital administrators and investors. She strategically allocates resources to initiatives that build brand equity, foster market adoption, and ultimately contribute to the company's valuation and impact.
Denise Terry's career background reflects a deep expertise in healthcare and life sciences marketing. She brings a wealth of experience in strategic communications, brand management, and market development from previous leadership roles within the biotech and pharmaceutical industries. Her extensive background has equipped her with a profound understanding of complex scientific concepts and the ability to articulate their value in a competitive marketplace. This blend of scientific acumen and marketing prowess makes her an invaluable asset in a field as specialized as infectious disease diagnostics.
While Denise Terry is not a traditional financial investor in other companies, her 'notable investments' are evident in the strategic marketing initiatives she spearheads at Karius, Inc. These include successful campaigns that have significantly increased awareness and adoption of the Karius Test, contributing directly to the company's growth and market leadership. Her strategic vision has helped Karius navigate the complexities of the diagnostic market, establishing the company as a trusted leader in precision medicine. Her work ensures that Karius' innovations reach the patients who need them most, representing a significant investment in public health and medical advancement. Her contributions are vital to Karius' ability to attract further investment and partnerships, solidifying its position as a transformative force in healthcare.
Denise Terry is the Head of Marketing at Karius, Inc., a leading company in infectious disease diagnostics. She is responsible for developing and executing strategic marketing initiatives to drive brand awareness, market adoption, and commercial growth for Karius' innovative technologies.
As Head of Marketing, Denise Terry's 'investments' are strategic in nature, focusing on initiatives that enhance Karius, Inc.'s brand equity, market penetration, and overall commercial success. This includes investing in brand development, market education, digital marketing campaigns, and strategic communications to drive the adoption of Karius' infectious disease diagnostics.
Denise Terry works at Karius, Inc., a biotechnology company specializing in next-generation sequencing liquid biopsies for the rapid and accurate detection of infectious diseases.
